Vaxcell-Bio Therapeutics (XKRX:323990) FCF Margin % : -16,231.59% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Vaxcell-Bio Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vaxcell-Bio Therapeutics's Free Cash Flow for the three months ended in Mar. 2024 was ₩-4,323.61 Mil. Vaxcell-Bio Therapeutics's Revenue for the three months ended in Mar. 2024 was ₩26.64 Mil. Therefore, Vaxcell-Bio Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was -16,231.59%.

As of today, Vaxcell-Bio Therapeutics's current FCF Yield % is -3.16%.

The historical rank and industry rank for Vaxcell-Bio Therapeutics's FCF Margin % or its related term are showing as below:

XKRX:323990' s FCF Margin % Range Over the Past 10 Years
Min: -70112.16 Med: -70112.16 Max: -43557.48
Current: -43557.48

During the past 5 years, the highest FCF Margin % of Vaxcell-Bio Therapeutics was -43557.48%. The lowest was -70112.16%. And the median was -70112.16%.

XKRX:323990's FCF Margin % is ranked worse than
96.73% of 1040 companies
in the Biotechnology industry
Industry Median: -139.2 vs XKRX:323990: -43557.48

Vaxcell-Bio Therapeutics FCF Margin % Historical Data

The historical data trend for Vaxcell-Bio Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcell-Bio Therapeutics FCF Margin % Chart

Vaxcell-Bio Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-70,112.16

Vaxcell-Bio Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial														-	-	-	-	-16,231.59

Competitive Comparison of Vaxcell-Bio Therapeutics's FCF Margin %

For the Biotechnology subindustry, Vaxcell-Bio Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxcell-Bio Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxcell-Bio Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vaxcell-Bio Therapeutics's FCF Margin % falls into.

Vaxcell-Bio Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vaxcell-Bio Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-9621.492	/	13.723
	=	-70,112.16 %

Vaxcell-Bio Therapeutics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4323.608	/	26.637
	=	-16,231.59 %

Vaxcell-Bio Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vaxcell-Bio Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxcell-Bio Therapeutics (XKRX:323990) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcell-Bio Therapeutics (XKRX:323990) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12-55, Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Yeosu, KOR, 58141

Website

http://www.vaxcell-bio.com

Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.

Vaxcell-Bio Therapeutics (XKRX:323990) Headlines

No Headlines